MAM
BLUE

Monaco Asset Management’s bluebird bio BLUE Stock Holding History

Monaco Asset Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-7,500
Closed -$207K – 61
2023
Q4 		$207K Buy
+7,500
New +$457K 0.06% 73
2023
Q1 		– Sell
-2,500
Closed -$346K – 71
2022
Q4 		$346K Sell
2,500
-1,500
-38% -$211K 0.1% 70
2022
Q3 		$506K Sell
4,000
-11,307
-74% -$1.28M 0.19% 54
2022
Q2 		$1.27M Buy
+15,307
New +$1.19M 0.55% 35

Other funds holding BLUE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Monaco Asset Management's BLUE Position: Q1 2024 in Review

Monaco Asset Management sold out of bluebird bio (BLUE) in Q1 2024, closing a stake of 7,500 shares — an estimated $207K sold.

Monaco Asset Management first reported a position in BLUE in Q2 2022 and held it in 4 quarters. The position peaked at $1.27M in Q2 2022. 158 funds tracked by Wall St. Rank hold BLUE as of Q1 2024.

  • Monaco Asset Management reported no remaining bluebird bio position as of Q1 2024 after selling out during the quarter.
  • Monaco Asset Management sold 7,500 bluebird bio shares in Q1 2024, an estimated $207K.
  • Monaco Asset Management first reported a position in bluebird bio in Q2 2022 and held it in 4 quarters.
  • Monaco Asset Management's bluebird bio position peaked at $1.27M in Q2 2022.
  • 158 funds tracked by Wall St. Rank held bluebird bio as of Q1 2024.

Based on Monaco Asset Management's 13F filing for Q1 2024, filed 9 May 2024.